Zkusit zdarma
Verve Therapeutics, Inc.

Verve Therapeutics, Inc.

VERV
Cena:
 
 
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly

Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly

13:16 17-06-2025

VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's...

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

11:11 17-06-2025

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t...

Why Verve Therapeutics Stock Is Skyrocketing Today

Why Verve Therapeutics Stock Is Skyrocketing Today

11:05 17-06-2025

Shares of Verve Therapeutics (VERV 76.24%) were skyrocketing 75.7% higher as of 10:50 a.m. ET on Tue...

Biotech Stock Surging on Billion-Dollar Buyout

Biotech Stock Surging on Billion-Dollar Buyout

9:53 17-06-2025

Biotech stock Verve Therapeutics Inc (NASDAQ:VERV) is up 75.3% to trade at $10.99 at last check ami...

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover

9:14 17-06-2025

Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing compa...

Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

8:27 17-06-2025

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Verve (Nasdaq: VERV) for possible breach...

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

6:45 17-06-2025

Verve's leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by...

What Makes Verve Therapeutics (VERV) a New Buy Stock

What Makes Verve Therapeutics (VERV) a New Buy Stock

13:01 13-06-2025

Verve Therapeutics (VERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab...

Verve Therapeutics (VERV) Just Reclaimed the 200-Day Moving Average

Verve Therapeutics (VERV) Just Reclaimed the 200-Day Moving Average

10:32 06-06-2025

From a technical perspective, Verve Therapeutics (VERV) is looking like an interesting pick, as it j...

Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High?

Wall Street Analysts See a 367.86% Upside in Verve Therapeutics (VERV): Can the Stock Really Move This High?

11:02 05-06-2025

The consensus price target hints at a 367.9% upside potential for Verve Therapeutics (VERV). While e...

Verve Therapeutics to Participate in Upcoming Investor Conferences

Verve Therapeutics to Participate in Upcoming Investor Conferences

7:00 28-05-2025

BOSTON , May 28, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a ...

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates

9:16 14-05-2025

Verve Therapeutics (VERV) came out with a quarterly loss of $0.35 per share versus the Zacks Consens...

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2025 Financial Results

7:00 14-05-2025

Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating d...

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street

1 Beaten-Down Stock That Could Skyrocket By 321%, According to Wall Street

7:53 29-04-2025

Equity markets have been volatile this year due to macroeconomic and geopolitical factors. Many of t...

Why Verve Therapeutics Zoomed 40% Higher This Week

Why Verve Therapeutics Zoomed 40% Higher This Week

18:36 18-04-2025

Good news from the laboratory and a clutch of bullish analyst notes were the drivers behind Verve Th...

VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study

VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study

13:30 15-04-2025

Verve Therapeutics stock rises on demonstrating superior LDL-C lowering ability in a phase Ib study ...

Why Verve Therapeutics Is Skyrocketing Today

Why Verve Therapeutics Is Skyrocketing Today

12:43 15-04-2025

Verve Therapeutics (VERV 22.57%) stock is seeing explosive gains Tuesday. The biotech company's shar...

Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose

Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose

11:34 14-04-2025

Verve Therapeutics Inc VERV on Monday released initial data from the Heart-2 Phase 1b trial of VERVE...

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose

7:00 24-03-2025

BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a...

Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates

Verve Therapeutics (VERV) Reports Q4 Loss, Tops Revenue Estimates

9:25 27-02-2025

Verve Therapeutics (VERV) came out with a quarterly loss of $0.58 per share versus the Zacks Consens...

close

LILLY COMPLETES ACQUISITION OF VERVE THERAPEUTICS TO ADVANCE ONE-TIME TREATMENTS FOR PEOPLE WITH HIGH CARDIOVASCULAR RISK

25-07-2025
INDIANAPOLIS , JULY 25, 2025 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) TODAY ANNOUNCED THE S...
Více zde

LILLY AND VERVE ANNOUNCE EXPIRATION OF VERVE TENDER OFFER

24-07-2025
INDIANAPOLIS , JULY 24, 2025 /PRNEWSWIRE/ -- ELI LILLY AND COMPANY (NYSE: LLY) AND VERVE THERAPEUTIC...
Více zde

$HAREHOLDER ALERT: CLASS ACTION ATTORNEY JUAN MONTEVERDE INVESTIGATES THE MERGER OF VERVE THERAPEUTICS, INC. (NASDAQ: VERV)

20-06-2025
NEW YORK, JUNE 20, 2025 (GLOBE NEWSWIRE) -- CLASS ACTION ATTORNEY JUAN MONTEVERDE WITH MONTEVERDE & ...
Více zde

VERVE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES ADEQUACY OF PRICE AND PROCESS IN PROPOSED SALE OF VERVE THERAPEUTICS, INC. - VERV

18-06-2025
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--FORMER ATTORNEY GENERAL OF LOUISIANA CHARLES C. FOTI, JR., ...
Více zde

VERV STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF VERVE THERAPEUTICS, INC. IS FAIR TO SHAREHOLDERS

17-06-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER T...
Více zde

SHAREHOLDER ALERT: THE ADEMI FIRM INVESTIGATES WHETHER VERVE THERAPEUTICS, INC. IS OBTAINING A FAIR PRICE FOR ITS PUBLIC SHAREHOLDERS

17-06-2025
MILWAUKEE--(BUSINESS WIRE)--THE ADEMI FIRM IS INVESTIGATING VERVE (NASDAQ: VERV) FOR POSSIBLE BREACH...
Více zde

LILLY TO ACQUIRE VERVE THERAPEUTICS TO ADVANCE ONE-TIME TREATMENTS FOR PEOPLE WITH HIGH CARDIOVASCULAR RISK

17-06-2025
VERVE'S LEADING PROGRAMS AIM TO DELIVER LIFELONG CARDIOVASCULAR RISK REDUCTION WITH A SINGLE DOSE BY...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-06-2025
BOSTON, JUNE 02, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

VERVE THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

28-05-2025
BOSTON , MAY 28, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

VERVE THERAPEUTICS ANNOUNCES PIPELINE PROGRESS AND REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS

14-05-2025
REPORTED POSITIVE INITIAL DATA FROM THE HEART-2 PHASE 1B CLINICAL TRIAL OF VERVE-102 DEMONSTRATING D...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-05-2025
BOSTON , MAY 02, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

VERVE THERAPEUTICS ANNOUNCES POSITIVE INITIAL DATA FROM THE HEART-2 PHASE 1B CLINICAL TRIAL OF VERVE-102, AN IN VIVO BASE EDITING MEDICINE TARGETING PCSK9

14-04-2025
SINGLE INFUSION OF VERVE-102 LED TO DOSE-DEPENDENT DECREASES IN BLOOD PCSK9 AND LDL-C, WITH MEAN RED...
Více zde

VERVE THERAPEUTICS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR VERVE-102, AN IN VIVO BASE EDITING MEDICINE TARGETING PCSK9

11-04-2025
BOSTON, APRIL 11, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-04-2025
BOSTON, APRIL 04, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A...
Více zde

VERVE THERAPEUTICS ANNOUNCES CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION BY THE U.S. FDA FOR VERVE-102, AN INVESTIGATIONAL GENE EDITING MEDICINE DESIGNED TO DURABLY LOWER CHOLESTEROL AFTER A SINGLE DOSE

24-03-2025
BOSTON, MARCH 24, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-03-2025
BOSTON, MARCH 03, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A...
Více zde

VERVE THERAPEUTICS ANNOUNCES PIPELINE PROGRESS AND REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

27-02-2025
INITIAL DATA FROM THE HEART-2 PHASE 1B CLINICAL TRIAL OF VERVE-102 TARGETING PCSK9 EXPECTED IN THE S...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-02-2025
BOSTON, FEB. 03, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

KUEHN LAW ENCOURAGES INVESTORS OF VERVE THERAPEUTICS, INC. TO CONTACT LAW FIRM

31-01-2025
NEW YORK , JAN. 31, 2025 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVE...
Více zde

VERVE THERAPEUTICS TO PARTICIPATE IN THE GUGGENHEIM SECURITIES SMID CAP BIOTECH CONFERENCE

29-01-2025
BOSTON, JAN. 29, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST VERVE THERAPEUTICS, INC. (VERV) AND ENCOURAGES SHAREHOLDERS TO LEARN MORE ABOUT THE INVESTIGATION

26-01-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JANUARY 26, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVES...
Více zde

VERVE THERAPEUTICS, INC. (VERV) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES INVESTORS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

22-01-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JANUARY 22, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVES...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES VERVE THERAPEUTICS, INC. (VERV) SHAREHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

19-01-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JANUARY 19, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVES...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING VERVE THERAPEUTICS, INC. (VERV) AND ENCOURAGES SHAREHOLDERS TO CONNECT

15-01-2025
NEW YORK CITY, NY / ACCESSWIRE / JANUARY 15, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGAT...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES VERVE THERAPEUTICS, INC. (VERV) STOCKHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

12-01-2025
NEW YORK CITY, NY / ACCESSWIRE / JANUARY 12, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGAT...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST VERVE THERAPEUTICS, INC. (VERV) AND ENCOURAGES INVESTORS TO LEARN MORE ABOUT THE INVESTIGATION

08-01-2025
NEW YORK CITY, NY / ACCESSWIRE / JANUARY 8, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATI...
Více zde

VERVE THERAPEUTICS, INC. (VERV) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES SHAREHOLDERS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

05-01-2025
NEW YORK CITY, NY / ACCESSWIRE / JANUARY 5, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATI...
Více zde

VERVE THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-01-2025
BOSTON, JAN. 03, 2025 (GLOBE NEWSWIRE) -- VERVE THERAPEUTICS, A CLINICAL-STAGE COMPANY DEVELOPING A ...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING VERVE THERAPEUTICS, INC. (VERV) AND ENCOURAGES INVESTORS TO CONNECT

02-01-2025
NEW YORK, NY / ACCESSWIRE / JANUARY 2, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING PO...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGATING VERVE THERAPEUTICS, INC. (VERV) AND ENCOURAGES STOCKHOLDERS TO CONNECT

29-12-2024
NEW YORK CITY, NY / ACCESSWIRE / DECEMBER 29, 2024 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-07-25 01:00:008-KStáhnout
2025-07-25 00:00:008-KStáhnout
2025-07-15 01:00:008-KStáhnout
2025-07-15 00:00:008-KStáhnout
2025-06-17 01:00:008-KStáhnout
2025-06-17 00:00:008-KStáhnout
2025-06-10 01:00:008-KStáhnout
2025-06-10 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 01:00:0010-QStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-14 00:00:0010-QStáhnout
2025-04-14 01:00:008-KStáhnout
2025-04-14 00:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-05 00:00:0010-QStáhnout
2024-11-04 23:00:008-KStáhnout
2024-11-04 23:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-28 01:00:008-KStáhnout
2024-06-28 00:00:008-KStáhnout
2024-06-07 01:00:008-KStáhnout
2024-06-07 00:00:008-KStáhnout
2024-05-31 01:00:008-KStáhnout
2024-05-31 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-04-02 01:00:008-KStáhnout
2024-04-02 00:00:008-KStáhnout
2024-02-27 00:00:008-KStáhnout
2024-02-27 00:00:0010-KStáhnout
2024-02-26 23:00:008-KStáhnout
2024-02-26 23:00:0010-KStáhnout
2023-11-29 00:00:008-KStáhnout
2023-11-28 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-07 00:00:008-KStáhnout
2023-11-07 00:00:0010-QStáhnout
2023-11-06 23:00:008-KStáhnout
2023-11-06 23:00:0010-QStáhnout
2023-10-23 01:00:008-KStáhnout
2023-10-23 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-06-16 01:00:008-KStáhnout
2023-06-16 00:00:008-KStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-15 01:00:008-KStáhnout
2023-05-15 01:00:0010-QStáhnout
2023-05-15 00:00:008-KStáhnout
2023-05-15 00:00:0010-QStáhnout
2023-03-02 00:00:008-KStáhnout
2023-03-02 00:00:0010-KStáhnout
2023-03-01 23:00:008-KStáhnout
2023-03-01 23:00:0010-KStáhnout
2023-02-17 00:00:008-KStáhnout
2023-02-16 23:00:008-KStáhnout
2022-12-05 00:00:008-KStáhnout
2022-12-04 23:00:008-KStáhnout
2022-11-07 00:00:008-KStáhnout
2022-11-07 00:00:0010-QStáhnout
2022-11-06 23:00:008-KStáhnout
2022-11-06 23:00:0010-QStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-07-21 01:00:008-KStáhnout
2022-07-21 00:00:008-KStáhnout
2022-07-20 01:00:008-KStáhnout
2022-07-20 00:00:008-KStáhnout
2022-07-12 01:00:008-KStáhnout
2022-07-12 00:00:008-KStáhnout
2022-07-07 01:00:008-KStáhnout
2022-07-07 00:00:008-KStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-03-14 00:00:008-KStáhnout
2022-03-14 00:00:0010-KStáhnout
2022-03-13 23:00:008-KStáhnout
2022-03-13 23:00:0010-KStáhnout
2021-11-29 00:00:008-KStáhnout
2021-11-28 23:00:008-KStáhnout
2021-11-10 00:00:008-KStáhnout
2021-11-10 00:00:0010-QStáhnout
2021-11-09 23:00:008-KStáhnout
2021-11-09 23:00:0010-QStáhnout
2021-08-24 01:00:008-KStáhnout
2021-08-24 00:00:008-KStáhnout
2021-08-12 01:00:008-KStáhnout
2021-08-12 01:00:0010-QStáhnout
2021-08-12 00:00:008-KStáhnout
2021-08-12 00:00:0010-QStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
preloader